A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

Inclusion criteria

• Female subjects aged between 18-45 years (both ages inclusive)
• Fitzpatrick skin phototype I to VI.
• Subjects having IGA score of 2 and 3.
• Subjects who have not received any kind of treatment for acne 1 month before the start of the study.
• Subject free of excessive hair, cuts, abrasions, fissures, wounds, lacerations, or any other skin conditions on the face.
• Subjects who agree not to use any other product/treatment/home remedy/ except the provided products on their face during the study period

Exclusion criteria

• Subjects with known skin condition that may impact the assessment.
• Subjects with active Herpes labialis infection.
• Subjects known to have bleeding and clotting disorders (self-declared).
• Subjects known to have connective tissue disorders.
• Subjects with any other signs of significant local irritation or skin disease.
• Subjects currently taking any medication, which the investigator believes may influence the interpretation of the data.